Nanopath Secures $10M to Develop POC Diagnostics for Women’s Health
[ad_1] Nanopath, a molecular diagnostics company enabling high-quality molecular testing in minutes, has closed $10 million in Series A funding that will support development and commercialization of the company’s biosensing platform that […]
Nanopath Secures $10M to Develop POC Diagnostics for Women’s Health Read More »























